ABIVAX
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
ABVX | PA
Overview
Corporate Details
- ISIN(s):
- FR0012333284 (+1 more)
- LEI:
- 969500D8TMNB184OJU95
- Country:
- France
- Address:
- 7 BOULEVARD HAUSSMANN, 75009 PARIS
- Website:
- https://www.abivax.com
- Sector:
- Manufacturing
Description
Abivax is a clinical-stage biotechnology company developing therapeutics for chronic inflammatory diseases by regulating the immune system. The company's scientific approach is centered on harnessing microRNA (miRNA) biology. Its lead drug candidate, obefazimod, is an investigational, once-daily, oral small molecule with a novel mechanism of action that enhances the expression of miR-124, a natural regulator of the inflammatory response. The primary development program for obefazimod focuses on ulcerative colitis, for which the company has reported positive Phase 3 clinical trial results. Abivax is also investigating the candidate for the treatment of Crohn's disease and other inflammatory conditions, while exploring follow-on compounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-06 08:00 |
Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis publ…
|
English | 20.8 KB | ||
| 2022-09-02 20:40 |
Abivax annonce la mise à disposition d’un prospectus dans le cadre de son augme…
|
French | 133.8 KB | ||
| 2022-09-02 20:40 |
Abivax publishes a prospectus in the context of its capital increase
|
English | 9.0 KB | ||
| 2022-09-02 07:32 |
ABIVAX: ABIVAX ANNONCE LE SUCCES D’UN FINANCEMENT CROSS-OVER SURSOUSCRIT DE 49,…
|
French | 336.5 KB | ||
| 2022-09-02 07:30 |
Abivax annonce le succès d’un financement cross-over sursouscrit de 49,2 millio…
|
French | 364.3 KB | ||
| 2022-09-02 07:30 |
ABIVAX: Abivax announces successful oversubscribed EUR 49.2M cross-over financi…
|
English | 57.0 KB | ||
| 2022-08-31 18:30 |
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits …
|
French | 248.2 KB | ||
| 2022-08-16 21:10 |
Abivax annonce un changement au sein de sa gouvernance
|
French | 164.2 KB | ||
| 2022-08-16 21:10 |
Abivax announces a change in its governance
|
English | 11.9 KB | ||
| 2022-08-04 18:00 |
Abivax : Le programme clinique de phase 3 avec obefazimod dans la rectocolite h…
|
French | 231.9 KB | ||
| 2022-08-04 18:00 |
Abivax phase 3 program with obefazimod in ulcerative colitis progresses with US…
|
English | 15.5 KB | ||
| 2022-07-28 18:00 |
ABIVAX : Bilan semestriel du contrat de liquidité au 30 juin 2022.
|
French | 321.2 KB | ||
| 2022-07-28 18:00 |
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits …
|
French | 248.1 KB | ||
| 2022-06-20 18:00 |
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits …
|
French | 248.1 KB | ||
| 2022-06-10 18:00 |
Abivax annonce les résultats de son Assemblée générale ordinaire annuelle et ex…
|
French | 139.3 KB |
Automate Your Workflow. Get a real-time feed of all ABIVAX filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ABIVAX
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ABIVAX via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-11 | N/A | Other | Buy | 319,107 | N/A |
| 2024-03-01 | N/A | Other | Buy | 7,000 | 91,557.90 EUR |
| 2023-12-19 | N/A | Other | Sell | 50,000 | 482,500.00 EUR |
| 2023-12-11 | N/A | Other | Sell | 2,062 | 19,382.80 EUR |
| 2023-11-13 | N/A | Other | Buy | 4 | 39.84 EUR |
| 2023-07-13 | N/A | Other | Sell | 192,781 | 3,101,480.01 EUR |
| 2023-03-27 | N/A | Other | Other | 38,461 | 249,996.50 EUR |
| 2023-02-27 | N/A | Other | Other | 1,535,000 | 9,977,500.00 EUR |
Peer Companies
